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Binding of brassinolide to the brassinosteroid-insenstive 1(BRI1) receptor kinase promotes
interaction with its co-receptor, BRI1-associated receptor kinase 1 (BAK1). Juxtaposition of
the kinase domains that occurs then allows reciprocal transphosphorylation and activation
of both kinases, but details of that process are not entirely clear. In the present study
we show that the carboxy (C)-terminal polypeptide of BAK1 may play a role. First, we
demonstrate that the C-terminal domain is a strong inhibitor of the transphosphorylation
activity of the recombinant BAK1 cytoplasmic domain protein. However, recombinant BAK1
lacking theC-terminal domain is unable to transactivate the peptide kinase activity of BRI1 in
vitro. Thus, the C-terminal domain may play both a positive and negative role. Interestingly,
a synthetic peptide corresponding to the full C-terminal domain (residues 576–615 of
BAK1) interacted with recombinant BRI1 in vitro, and that interaction was enhanced by
phosphorylation at the Tyr-610 site. Expression of a BAK1 C-terminal domain truncation
(designated BAK1-CT-Flag) in transgenic Arabidopsis plants lacking endogenous bak1
and its functional paralog, bkk1, produced plants that were wild type in appearance but
much smaller than plants expressing full-length BAK1-Flag. The reduction in growth may
be attributed to a partial inhibition of BR signaling in vivo as reﬂected in root growth assays
but other factors are likely involved as well. Our working model is that in vivo, the inhibitory
action of the C-terminal domain of BAK1 is relieved by binding to BRI1. However, that
interaction is not essential for BR signaling, but other aspects of cellular signaling are
impacted when the C-terminal domain is truncated and result in inhibition of growth.
These results increase the molecular understanding of the C-terminal domain of BAK1
as a regulator of kinase activity that may serve as a model for other receptor kinases.
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INTRODUCTION
Plants contain a large family of receptor-like kinases that are
structurally similar to animal receptor kinases and consist of an
extracellular domain connected by a single-pass transmembrane
domain to the cytoplasmic domain of the protein. The cytoplasmic
polypeptide contains a protein kinase domain that is ﬂanked by
an N-terminal juxtamembrane domain and C-terminal polypep-
tide (Shiu and Bleecker, 2001). Animal receptor kinases are usually
tyrosine kinases whereas the plant receptor kinases are classiﬁed as
Ser/Thr kinases on the basis of sequence analysis, but recent work
suggests that at least some are dual-speciﬁcity kinases that can also
autophosphorylate on tyrosine residues (Karlova et al., 2009; Oh
et al., 2009a,b, 2011, 2012). The model for plant receptor kinase
signaling is based on studies with the receptor kinase, BRI1, and its
co-receptor, BAK1, that together function in brassinosteroid (BR)
signaling. Current thinking is that binding of the steroid ligand
to the extracellular domain of BRI1 (Kinoshita et al., 2005) allows
docking of the co-receptor, BAK1, initially through interactions
of their leucine-rich repeat extracellular domains (Hothorn et al.,
2011; She et al., 2011). Recent studies with recombinant extra-
cellular domains of BRI1 and SERK1 structurally characterized
a BRI1-BL-SERK1 complex that forms an integral part of the
BRI1 ligand-binding pocket (Santiago et al., 2013). However, in
the context of the full-length proteins, it is likely that interactions
between other domains also contribute to signaling. For example,
the recombinant cytoplasmic domains of BRI1 and BAK1 interact
in vitro (Li et al., 2002) suggesting that several regions of the recep-
tor and co-receptor may contribute to the speciﬁcity and strength
of the overall interaction. However, whether simple proximity can
explain the reciprocal kinase activation that occurs (Wang et al.,
2008) is not known.
Although the kinase domain contains the structures and
residues required for phosphoryl transfer from ATP to peptide or
protein substrates, the ﬂanking domains often play an important
regulatory role and that function can bemodulated by phosphory-
lation of residues within the domains. For example with BRI1, the
juxtamembrane domain is an activator of the kinase domain (Oh
et al., 2009b,2012); when the juxtamembrane domain is truncated,
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autophosphorylation of recombinant BRI1 protein is completely
inhibited. In the full-length BRI1 cytoplasmic domain protein, the
activating role of the juxtamembrane domain of BRI1 is attenu-
ated by phosphorylation of Tyr-831 (Oh et al., 2009b). In contrast,
the BRI1 C-terminal polypeptide is an inhibitor of kinase activ-
ity (Wang et al., 2005b; Oh et al., 2009b), and its removal from
BRI1 expressed in transgenic plants leads to a hyperactive recep-
tor (Wang et al., 2005b). In the full-length BRI1 protein in vivo, it
is thought that the inhibitory role of the C-terminal polypeptide
can be relieved by phosphorylation of several sites located within
the sequence (Wang et al., 2005b). However, little is known about
the role of ﬂanking domains with other receptor kinases, and in
particular, whether and how the ﬂanking domains may contribute
to receptor kinase activity and the overall receptor:co-receptor
interaction.
In the present study, we show that the C-terminal domain of
BAK1 inhibits the transphosphorylation activity of BAK1 but is
essential for BAK1 to activate BRI1 activity in vitro. However, the
C-terminal domain is not essential for BR signaling in vivo sug-
gesting that other mechanisms provide proper positioning so that
the kinase domains of BRI1 and BAK1 can effectively transphos-
phorylate and activate the signaling cascade. It is also interesting
that in the absence of the C-terminal domain of BAK1 plant
growth is signiﬁcantly inhibited suggesting that other (presently
unknown) factors are affected by removal of the C-terminal
domain. Overall, the results establish an important role for the
C-terminal domain of BAK1 and perhaps other receptor kinases as
well.
MATERIALS AND METHODS
PLANT GROWTH AND TRANSFORMATION
Arabidopsis thaliana ecotype Ws-2 was the background for the
bri1-5 mutant and Col-0 was the background for transgen-
ics in the null bak1-4 bkk1 mutant background. Expression of
BAK1::BAK1-Flag (wild type and site-directed mutants) in the
bak1-4 bkk1-1 double mutant background was achieved by trans-
forming the viable heterozygous BAK1-4 /bkk1-1 bkk1-1 (He et al.,
2007) with the pBIB-Hyg-PK1-BAK1-Flag construct and screen-
ing for homozygous bak1-4 bkk1-1 double mutants expressing
the transgene as described (Wang et al., 2008). PK1 refers to the
native promoter of BAK1 located in the 1.7 Kb sequence upstream
of the gene. All site-directed mutants were produced using the
Quik Change XL Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA, USA) and a full-length BAK1 cDNA with C-terminal
Flag epitope tag as template. As speciﬁed, serial truncations of
the C-terminal domain were made by sequentially removing ﬁve
amino acid segments between residues 615 and 580. In addition,
the cDNA lacking the complete C-terminal domain was used to
produce directedmutants with the following substitutions: Y304F,
Y363F,Y365F,Y403F,Y443F,Y463F, andY478F. All constructs were
sequenced in both directions to verify speciﬁc mutations and lack
of additional mutations.
Seeds were surface sterilized, kept at 4◦C for 2 days, and
then sown on germination medium [1/2 strength Murashige and
Skoog salt and vitamins medium (PhytoTechnology Laboratories,
Lenexa, KS,USA), supplemented with 0.8% (w/v) agar, 30mg L−1
hygromycin B (Sigma-Aldrich, St. Louis, MO, USA) and 2%
(w/v) sucrose, pH 5.7]. For phenotypic analysis between plants
expressing BAK1-Flag and BAK1-CT-Flag, plates containing
half-strength MS medium (0.8% agar) were kept at 22◦C with
an 8-h photoperiod for 9 days. Seedlings were then transferred to
soil and grown in the same temperature and light conditions to
analyze phenotype.
To measure BL inhibition of root growth, seeds were sterilized
with 100% ethanol and germinated on MS plates containing the
indicated BL concentration. After 2 days at 4◦C for stratiﬁcation,
the seeds were grown vertically under long day conditions (16 h
light/8 h dark) at 25◦C. After 5 days, root length was measured
and expressed as a percentage of the control length.
SITE-DIRECTED MUTAGENESIS OF Flag-BAK1 CYTOPLASMIC DOMAIN
AND RECOMBINANT PROTEIN STUDIES
After sequencing to conﬁrm mutated regions, BAK1-CD and its
mutations were expressed in BL21 (DE3) pLysS cells (Novagen,
Gibbstown, NJ, USA). Cultures were induced with 0.3 mM IPT-
Gat 25◦C for 16 h and the soluble recombinant protein produced
was puriﬁed using anti-Flag M2 afﬁnity gel (Sigma-Aldrich, St.
Louis, MO, USA). After elution from the beads, the protein solu-
tion was dialyzed against a 1000X volume of buffer containing
20 mM MOPS, pH 7.5, and 1 mM DTT. The ability of Flag-BAK1
and (wild type and C-terminal truncation mutant) to transphos-
phorylate Flag-BRI1 and increase its kinase activity wasmonitored
using the BR13 peptide (sequence: GRJKKIASVEJJKK, where J is
norleucine; produced by Bethyl Laboratories, Montgomery, TX,
USA) as substrate as previously described using the ﬁlter binding
assay (Wang et al., 2008).
PREPARATION OF MICROSOMAL MEMBRANES AND
IMMUNOPURIFICATION OF BAK1-Flag
Microsomal membranes were isolated from harvested tissues (Oh
et al., 2009b), solubilized with Triton X-100, and incubated with
anti-Flag M2 afﬁnity gel at 4◦C overnight with shaking. After
incubation, anti-Flag M2 afﬁnity beads were washed once with
IPDB solution [20 mM MOPS (pH 7.5), 1 mM DTT, 1 mM
EDTA, 4 mM NaF, 0.1 μM MCLR, 0.2 mM AEBSF, 0.2 mM BZ-
HCl, 0.2 mM CA, 0.4 μM E64, 0.1% TritonX-100, and 10 mM
MgCl2]; twice with PBS150 [5 mM NaP, 150 mM NaCl); once
with PBS50 (5 mM NaP, 50 mM NaCl); and ﬁnally two washes
with IPDB solution. After the ﬁnal wash step, an aliquot of 1.5X
SDSbufferwas added and themixturewas heated at 95◦C for 5min
to elute BAK1-Flag and BAK1-CT-Flag proteins. Recombinant
Flag-BAK1 was immunopuriﬁed using anti-Flag M2 afﬁnity gel
(Sigma, St. Louis, MO, USA) as previously described (Wang et al.,
2005a, 2008).
IMMUNOBLOT ANALYSIS
Immunoprecipitated full-length BAK1-Flag or recombinant Flag-
BAK1 proteins were subjected to SDS-PAGE followed by transfer
to PVDF membranes and immunoblot analysis using anti-Flag
antibodies (1:5,000 dilution), anti-phosphothreonine antibod-
ies (1:500 dilution), and anti-phosphotyrosine antibodies (1:500
dilution). Immunoblots were scanned using an Odyssey Infrared
Imaging System (LI-COR Bioscience, Lincoln, NE, USA) for
visualization. Blots stained with ProQ Diamond phosphoprotein
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stain (Invitrogen, Carlsbad, CA, USA) were scanned
using a Typhoon Molecular Dynamics phosphor/ﬂuorescence
imager.
PEPTIDE INTERACTIONS STUDIES
The real-time binding of Flag-BRI1 (analyte) to immobilized
BAK1 C-terminal domain peptides was monitored using an Octet
QK (Pall ForteBio Corp, Menlo Park, CA, USA). The binding
buffer contained 50 mM MOPS (pH 7.5), 0.01% (v/v) Triton
X-100, 20 mM NaCl and 5 mM MgCl2 unless speciﬁed other-
wise. Synthetic peptides corresponding to the C-terminal domain
of BAK1 (residues 576–615) were produced with an N-terminal
biotin group and either no additional modiﬁcations (CT), with
phosphorylation of the Tyr-610 residue (CTpY610) or phospho-
rylation of the Ser-612 residue (CTpS612). All peptides were
synthesizedbyGenScriptCorp (Piscataway,NJ,USA). Biotinylated
peptides were captured to SA Streptavidin Biosensors followed by
binding of the analyte Flag-BRI1 from a 100 μg/mL solution or
as otherwise noted. One-shot KD was calculated based on the 1:1
model and the average KD was extracted from binding results for
four different concentrations of the analyte.
RESULTS AND DISCUSSION
THE JUXTAMEMBRANE AND C-TERMINAL DOMAINS REGULATE BAK1
KINASE TRANSPHOSPHORYLATION ACTIVITY AND SPECIFICITY
As an initial approach to study the role of ﬂanking domains, we
used the Flag-BAK1 cytoplasmic domain construct to produce a
set of deletion mutants lacking the juxtamembrane (J) domain,
the C-terminal domain, or both. All constructs had the kinase (K)
domain with a Flag-epitope tag at the N-terminus (Figure 1A).
Interestingly, only the constructs with the juxtamembrane domain
(BAK1-JKC and BAK1-JK) had robust autophosphorylation on
threonine and tyrosine residues (Figure 1B). By monitoring the
phosphorylation of E. coli proteins during production of the
recombinant protein kinases (Chou et al., 2012; Wu et al., 2012),
we could also assess the effect of ﬂanking domain removal on
transphosphorylation activity. As shown in Figure 1C, recom-
binant BAK1 lacking the juxtamembrane domain was unable
to transphosphorylate bacterial proteins on threonine or tyro-
sine residues, whereas constructs with the juxtamembrane were
active. However, strongest transactivation was observed when
the C-terminal domain was removed (BAK1-JK compared to
BAK1-JKC; Figure 1C). Collectively, these results suggest that the
juxtamembrane domain is an activator of the kinase domain, both
in terms of auto- and trans-phosphorylation activity, and that the
C-terminal domain is a strong inhibitor in particular of transpho-
sphorylation activity. Alternatively, the C-terminal domain may
affect speciﬁcity of the BAK1 kinase domain such that additional
bacterial proteins and phosphorylation motifs are recognized
when the C-terminal domain is truncated, which could also result
in increased transphosphorylation activity. It will be important in
future studies to distinguish between increased activity per se and
altered speciﬁcity.
Another interesting point is that the BAK1-JK truncation had
strong autophosphorylation on tyrosine residues (Figure 1B).
This was unexpected, because with the full-length BAK1 cyto-
plasmic domain protein, Tyr-610 in the C-terminal domain is a
FIGURE 1 |The juxtamembrane domain is a positive regulator while
the C-terminal domain is a negative regulator of recombinant BAK1
transphosphorylation activity. (A) Schematic representation of the
Flag-BAK1-cytoplasmic domain truncations used in these experiments. J, K,
and C, refer to the juxtamembrane, kinase, and C-terminal domains,
respectively. Residue numbers at the domain interfaces are shown.
(B) Autophosphorylation activity of the recombinant proteins measured
with Pro-Q Diamond stain and immunoblotting with antiphosphotyrosine
(pY) or antiphosphothreonine (pT) antibodies. Recombinant proteins were
detected by immunoblotting with anti-Flag or peptide antibodies directed
against the C-terminus of BAK1 (anti-BAK1; antigen sequence:
DSTSQIENEYPSGPRCOOH ). Note the lack of cross reactivity of the
anti-BAK1 antibodies with truncation mutants lacking the C-terminal
domain. (C)Transphosphorylation of E. coli proteins that occurred during
production of the BAK1 proteins shown in (A). Phosphorylation of proteins
was assessed as described in (B), except that proteins were visualized by
staining with Coomassie Brilliant Blue (CBB).
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major site of autophosphorylation such that tyrosine autophos-
phorylation of the Y610F directed mutant is substantially reduced
relative to the wild type protein (Oh et al., 2010). We predicted,
therefore, that the BAK1-JK truncation mutant would have much
reduced tyrosine autophosphorylation; however, that was not
observed suggesting that additional tyrosine residues located in
the kinase domain may be autophosphorylated in the absence of
the C-terminal domain. To explore this possibility, we generated
site-directed mutants by individually replacing each of the seven
tyrosine residues in the kinase domain with phenylalanine. As
expected from studies with the full-length cytoplasmic domain
protein (Oh et al., 2010), Tyr-463 was also essential for kinase
activity of the BAK1-JK truncation mutant as the Y463F directed
mutant had strongly reduced autophosphorylation indicative of
a kinase-inactive protein (Figure 2). The surprising result was
that the Y304F and Y363F directed mutants had substantially
reduced tyrosine autophosphorylation because in the full-length
cytoplasmic domain proteins these substitutions have relatively
little effect on the overall level of tyrosine autophosphorylation
(Oh et al., 2010). Thus, Tyr-304 and Tyr-363 emerge as potential
new sites of tyrosine autophosphorylation when the inhibitory
C-terminal domain is removed. Threonine autophosphorylation
was also increased when the C-terminal domain was truncated
(Figure 2), but whether that was the result of autophosphorylation
FIGURE 2 | Effect of site-directed mutagenesis of kinase-domain
tyrosine residues in Flag-BAK1-JK on autophosphorylation of the
recombinant proteins. (A) Autophosphorylation status as measured with
Pro-Q Diamond stain and immunoblotting with antiphosphotyrosine (pY) or
antiphosphothreonine (pT) antibodies. Recombinant proteins were
detected by immunoblotting with anti-Flag antibodies. (B) Densitometry
analysis of immunoblots shown in (A). Phosphoamino acid signals are
normalized with the amount of recombinant protein, determined by cross
reaction with anti-Flag antibodies.
of new sites or increased stoichiometry of known sites is not clear
and was not explored in the present study.
As an initial approach to determine which regions of the
C-terminal domain are crucial to the transphosphorylation activ-
ity of BAK1, we constructed a nested series of truncations
FIGURE 3 | Identification of residues in the C-terminal domain
responsible for inhibition of BAK1 transphosphorylation activity.
(A) Serial deletions of the C-terminal domain were constructed to produce
truncation mutants ending with the indicated residue. (B) Analysis of
transphosphorylationof the C-terminal truncation mutants by
immunoblotting with antibodies as described in the Figure 1 legend.
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that sequentially removed ﬁve amino acid segments from the
C-terminusof this ﬂanking region (Figure 3). The full-lengthFlag-
BAK1 cytoplasmic domain ends at residue 615 and only weakly
transphosphorylates bacterial proteins on tyrosine and threonine
relative to the BAK1-JK truncation mutant, which ends at residue
577. Removal of the last ﬁve residues of the C-terminal domain
(to generate the CT610mutant), substantially increased transpho-
sphorylation activity on tyrosine and threonine residues, whereas
the full effect required removal of the last twenty residues. Longer
deletions beyond the CT595 truncation did not result in any
further increase in transphosphorylation activity. These results
suggest that the last half of the C-terminal domain is responsible
for inhibition of transphosphorylation activity, possibly by inter-
acting with the kinase domain and restricting protein substrate
access to the active site.
PLANT GROWTH IS REDUCED BY EXPRESSION OF A TRUNCATED BAK1
LACKING THE C-TERMINAL DOMAIN
In general, expressing a hyper-activated form of a receptor
kinase would be expected to increase signaling in vivo. With
BR signaling, increased plant growth would be expected and
indeed was observed with plants expressing BRI1 lacking the
inhibitory C-terminal domain (Wang et al., 2005b). Consequently,
we anticipated that plants expressing the BAK1-CT-Flag trun-
cation mutant (Figure 4A) would have increased signaling and
enhanced growth; however, that result was not obtained. As
shown in Figure 4B, the BAK1-CT-Flag plants had smaller
roots when grown as seedlings on agar plates and the rosettes
remained substantially smaller than plants expressing full-length
BAK1-Flag during both vegetative and reproductive development
(Figure 4C). Expression levels of the BAK1-CT protein varied
among transgenic lines tested but were not responsible for the
reduced growth phenotype (Figure 4D). Moreover, both BAK1-
Flag and BAK1-CT-Flag were associated with BRI1 in vivo, as
the two proteins were co-immunoprecipitated from all transgenic
lines. Thus, the reduced growth was not the result of impaired
binding of BAK1-CT to BRI1 in vivo. Although growth of the
BAK1-CT-Flag plants was markedly reduced, rosette morphol-
ogy was not indicative of impaired BR signaling as petioles and
leaveswere relatively elongated unlike strong BR signalingmutants
(Clouse and Sasse, 1998).
In an attempt to determine the basis for the strong phenotype
of the transgenic plants expressing BAK1-CT-Flag, we examined
the ability of recombinant GST-BAK1-JK truncation mutant to
FIGURE 4 |The C-terminal domain of BAK1 is required for normal
vegetative and reproductive growth ofArabidopsis. (A) Schematic
representation of the constructs used to generate transgenic plants in the
null bak1bkk1 mutant background. (B) Root growth for seedlings on agar
plates growing in the light. (C) Reduced growth of transgenic plants
expressing BAK1-CT-Flag compared to BAK1-Flag during vegetative and
reproductive growth. (D) BRI1 protein co-immunoprecipitates with BAK1-Flag
or BAK1-CT-Flag.
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transactivate BRI1 in vitro, which mimics their interaction in
vivo and is thought to be essential for enhanced BR signaling
in vivo (Wang et al., 2008). This functional interaction can be
examined in vitro by monitoring the ability of BAK1 to increase
the peptide kinase activity of BRI1using the SP11 synthetic pep-
tide as substrate (Oh et al., 2000; Wang et al., 2008). As shown
in Figure 5 and as expected, Flag-BRI1 readily phosphorylated
the SP11 synthetic peptide whereas GST-BAK1 or the GST-BAK1-
JK truncation mutant did not. In addition, neither of the kinase
inactive mutants (Flag-mBRI1 and GST-mBAK1) displayed pep-
tide kinase activity. However, GST-BAK1 substantially increased
the ability of Flag-BRI1to transphosphorylate the synthetic pep-
tide substrate whereas the GST-BAK1-JK truncation mutant did
not (Figure 5). As expected, the kinase-inactive GST-mBAK1
did not stimulate BRI1 peptide kinase activity because BAK1
kinase activity is required for the transphosphorylation/activation
of BRI1 (Wang et al., 2008). It is important to note that the
inability of GST-BAK1-JK to activate BRI1 is not the result
of impaired kinase activity, as the C-terminal domain trunca-
tion mutant is active. The important conclusion is thatBAK1
C-terminal domain is required to fully activate BRI1, which is
recognized to be an important factor that regulates signaling lead-
ing to plant growth (Vert et al., 2005; Oh et al., 2009a; Clouse,
2011).
The above results suggest that reduced growth in the BAK1-
CT-Flag plants may be the result of attenuated BR signaling. To
test this notion, we examined the inhibition of root elongation
by high concentrations of BL (Clouse et al., 1996; Li et al., 2001).
As shown in Figure 6, concentrations of brassinolide above 1 nM
inhibited root elongation in the wild type BAK1-Flag plants to
a much greater extent than the bri1-5 plants, which is consistent
with the reducedBR signaling in the bri1-5 plants. Root elongation
in the BAK1-CT-Flag plants was inhibited by BL but to a lesser
extent than inplants expressingwild typeBAK1-Flag. These results
suggest that BR signaling was somewhat reduced by truncation of
FIGURE 5 | Activation of Flag-BRI1peptide kinase activity by GST-BAK1
but not GST-BAK1-JK or the kinase-inactive GST-mBAK1 directed
mutant monitored using the SP11 synthetic peptide substrate.The
increase in BRI1 activity requires an active BAK1 kinase with C-terminal
domain, which alone does not readily phosphorylate the SP11 peptide.
Values are means ± SEM; n = 3.
the C-terminal domain of BAK1, but perhaps cannot completely
explain the reduction in plant growth. It is possible that growth
is restricted as a combination of reduced BR signaling and other
factors that remain to be identiﬁed.
One potential factor for the reduced growth phenotype of
BAK1-CT-Flag plants could be activation of defense mecha-
nisms, which often results in growth inhibition (Zhu et al., 2013).
This might occur, for example, as the result of activation of FLS2
when the hyperactivated BAK1-CT-Flag protein is expressed.
Alternatively, removal of the C-terminal domain of BAK1 may
alter speciﬁcity of the kinase domain rather than activity per se.
As mentioned above, the increased transphosphorylation activ-
ity observed in E. coli (Figure 1C) may reﬂect altered speciﬁcity
(rather than increased activity) that allows the recombinant Flag-
BAK1-JK protein to phosphorylate a broader array of bacterial
proteins. If this broadened speciﬁcity occurred in planta, it may
result in inappropriate signaling causing growth inhibition. We
will test these possibilities in future experiments by analyzing
gene expression in BAK1-CT-Flag plants to ascertain whether
defense genes are activated in the absence of (apparent) external
triggers. We will also determine whether levels of FLS2 protein
are reduced, as FLS2 degradation follows its activation (Robatzek
et al., 2006). A third possibility that may explain altered signaling
byBAK1-CT-Flag is that the protein has altered subcellular local-
ization. At present we have no information about this aspect, but
in future studies will attempt to examine this using a GFP-tagged
construct.
BINDING OF THE BAK1 C-TERMINAL DOMAIN TO BRI1
The observation that removal of the C-terminal domain of BAK1
enhances transphosphorylation activity in situ but prevents the
proper activation of BRI1 in vitro suggests that the C-terminal
domain may play a speciﬁc role in the correct positioning of
BAK1 with BRI1 (at least in vitro). One possibility would be
that when the two receptor kinases are juxtaposed, the C-terminal
FIGURE 6 | Inhibition of root elongation by high concentrations of BL.
Root elongation in bri1-5 plants is relatively insensitive to BL as a result of
impaired BR signaling. Transgenic plants expressing BAK1-CT-Flag are
slightly less sensitive to BL compared to BAK1-Flag plants suggesting that
truncation of BAK1 results in some reduction in BR signaling.
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domain of BAK1 binds to BRI1, thereby helping to properly posi-
tion the two kinase domains while also relieving the inhibitory
effect of the C-terminal domain on BAK1 transphosphorylation
activity. To test this notion, we asked whether recombinant Flag-
BRI1 would bind to the immobilized C-terminal polypeptide of
BAK1. As shown in Figure 7A, with a synthetic peptide based
on the entire C-terminal domain of BAK1 (residues 576 to 615;
designated CT in Figure 7) as the immobilized ligand, recom-
binant Flag-BRI1 protein (analyte) interacted but only weakly.
However, robust binding of Flag-BRI1 was observed with the
C-terminal domain peptide phosphorylated at the Tyr-610 site
(designated CTpY610 in Figure 7). The increased binding could
not be attributed simply to adding negative charge to the polypep-
tide because the CT peptide phosphorylated at the Ser-612 site
(designated CTpS612) only supported slightly more binding than
the unphosphorylated CT peptide (Figure 7). Binding of Flag-
BRI1 to the CTpY610 peptide increased as pH of the reaction
mixture was reduced from pH 8–7, but binding to the immobi-
lized CT peptide was low and constant over the same pH range
(Figure 7B). Interestingly, early studies (Oh et al., 2000) with
recombinant Flag-BRI1 found that both autophosphorylation and
transphosphorylation (peptide kinase) activity had a pHoptimum
near 7.0, which is similar to the results of the present study. It
is conceivable that pH is affecting BRI1 overall conformation or
the charge of speciﬁc groups on the surface of the molecule, but
effects on the charge of the CT peptide could also be involved.
It is also worth noting that robust binding of Flag-BRI1 to the
CTpY610 peptide also required Mg2+; in the absence of the
divalent cation binding to the CT or CTpY610 was completely
prevented (Figure 7B). It is recognized that many protein kinases,
such as protein kinase A (Adams and Taylor, 1993; Bastidas et al.,
2013) bind divalent cationswith dramatic effects on kinase activity
and conformational changes could certainly be involved. In sup-
port of that notion, earlier work demonstrated that binding of
Flag-BRI1 to immobilized GST-BAK1 was completely dependent
on Mg2+ (Oh et al., 2010). The Mg2+-dependence of binding
in both systems suggests that the interactions are speciﬁc and
that “active” conformations of the kinases are required. Future
studies will determine whether divalent cation induced conforma-
tional changes occur and are responsible for the enhanced binding.
Greatest binding of Flag-BRI1 to the immobilized CTpY610 pep-
tide occurred at pH 7.0 with Mg2+ in the reaction mixture, and
under these conditions a KD for binding of ∼34 ± 3 nM was
estimated (Figure 7C), which is similar to the afﬁnity of the
interaction between GST-BAK1 and Flag-BRI1 in vitro (Oh et al.,
2010).
FIGURE 7 | Label-free binding of recombinant BRI1 protein to an
immobilized peptide based on the BAK1 C-terminal domain sequence
(residues 576–615). Binding was monitored in the Octet, which uses ﬁber
optic sensors to detect protein-protein or protein-peptide interactions using
biolayer interferometry. (A) Phosphorylation of theTyr-610 residue (CTpY610)
supports robust binding of Flag-BRI1 compared to phosphorylation of the
Ser-612 site (CTpS612) or the unphosphorylated peptide (CT). All reactions
were run at pH 7.0. (B) Binding of Flag-BRI1 to the CTpY610 peptide is
sensitive to pH and is strictly dependent on Mg2+, whereas binding to the CT
peptide is low, shows no pH dependence, but is also strictly dependent on
Mg2+. (C) Binding of various concentrations of Flag-BRI1 to the immobilized
CTpY610 peptide to estimate the binding afﬁnity.
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CONCLUSION
Our results support a model that involves inhibition of BAK1
kinase activity by its C-terminal domain, which we postulate can
be relieved by its binding to the cytoplasmic domain of BRI1 after
formation of the BRI1:BAK1 complex. Interestingly, the ﬂank-
ing domains of BRI1 (Oh et al., 2009b, 2012) and BAK1 (this
study) have similar effects on kinase activity, with the juxtamem-
brane domains activating while the C-terminal domains inhibit
kinase activity. In the case of BRI1, inhibition by the C-terminal
domain is relieved by autophosphorylation of residues within the
domain and expression of a BRI1-CT truncation mutant in
transgenic plants results in hyper-activation of BR signaling and
increased plant growth (Wang et al., 2005b). In contrast, inhi-
bition by the C-terminal domain of BAK1 is not relieved solely
by autophosphorylation and expression of BAK1-CT-Flag in
transgenic plants does not hyperactivate signaling and actually
results in reduced plant growth. The growth inhibition cannot
be completely attributed to reduced BR signaling (Figure 5B),
which is also supported by the observation that plants do not
have the morphology of BR signaling mutants (Figure 4C). We
speculate that other factors may be involved in reducing plant
growth, such as enhanced stress signaling in plants expressing
BAK1-CT-Flag, perhaps as a result of FLS2 activation, or inap-
propriate signaling that occurs as a result of altered speciﬁcity of
the BAK1-CT-Flag protein. These are important questions but
are beyond the scope of the present study. Much also remains
to be done with the possible role of the C-terminal domain
of BAK1 in its interaction with BRI1 resulting in BR signal-
ing. In particular, it will be interesting to determine whether
C-terminal domain binding between proteins applies to other
receptor:co-receptor kinase pairs as well. Our present results are
generally consistent with the previous report that C-terminal
epitope tags can affect BAK1 function in different signaling path-
ways (Ntoukakis et al., 2011). Our results extend this concept
to establish a role for the C-terminal domain itself at least with
BAK1 as co-receptor with BRI1 in BR signaling. Because BAK1
also serves as co-receptor with the leucine-rich repeat recep-
tor kinases ﬂagellin-sensitive 2 (FLS2) and elongation factor TU
receptor (EFR; Chinchilla et al., 2007), it will be interesting to
determine whether the C-terminal domain of BAK1 is essential
for these signaling pathways and we will explore this in future
studies.
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